1262 related articles for article (PubMed ID: 11335778)
21. Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease.
Kashiwai T; Tada H; Asahi K; Hidaka Y; Tamaki H; Iwatani Y; Amino N
Endocr J; 1995 Jun; 42(3):405-12. PubMed ID: 7670570
[TBL] [Abstract][Full Text] [Related]
22. Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease.
Kempers MJ; van Trotsenburg AS; van Rijn RR; Smets AM; Smit BJ; de Vijlder JJ; Vulsma T
J Clin Endocrinol Metab; 2007 Aug; 92(8):2984-91. PubMed ID: 17504907
[TBL] [Abstract][Full Text] [Related]
23. [TSH and thyroid hormone levels in newborn infants with hyperthyrotropinemia detected by screening tests, in newborn infants with goiter and those born to mothers with hyperthyroidism].
Rybakowa M; Markowska-Kraik E; Ostrowska J; Sołtysik-Wilk E; Sztefko K; Tomaszczyk B
Endokrynol Pol; 1985; 36(5):277-84. PubMed ID: 3841657
[No Abstract] [Full Text] [Related]
24. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
25. Central hypothyroidism resulting from pituitary suppression and peripheral thyrotoxicosis in a premature infant born to a mother with Graves disease.
Hashimoto H; Maruyama H; Koshida R; Okuda N; Sato T
J Pediatr; 1995 Nov; 127(5):809-11. PubMed ID: 7472842
[TBL] [Abstract][Full Text] [Related]
26. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
[TBL] [Abstract][Full Text] [Related]
27. Thyroid disorders of neonates born to mothers with Graves' disease.
Papendieck P; Chiesa A; Prieto L; Gruñeiro-Papendieck L
J Pediatr Endocrinol Metab; 2009 Jun; 22(6):547-53. PubMed ID: 19694202
[TBL] [Abstract][Full Text] [Related]
28. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.
McLachlan SM; Rapoport B
Thyroid; 2013 Jan; 23(1):14-24. PubMed ID: 23025526
[TBL] [Abstract][Full Text] [Related]
29. Foetal and neonatal thyroid disorders.
Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
[TBL] [Abstract][Full Text] [Related]
30. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
Bayer MF; Kriss JP; McDougall IR
J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
[TBL] [Abstract][Full Text] [Related]
31. Follow-up of newborns of mothers with Graves' disease.
Levy-Shraga Y; Tamir-Hostovsky L; Boyko V; Lerner-Geva L; Pinhas-Hamiel O
Thyroid; 2014 Jun; 24(6):1032-9. PubMed ID: 24472020
[TBL] [Abstract][Full Text] [Related]
32. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
[TBL] [Abstract][Full Text] [Related]
33. Management of neonates born to women with Graves' disease: a cohort study.
Besançon A; Beltrand J; Le Gac I; Luton D; Polak M
Eur J Endocrinol; 2014 Jun; 170(6):855-62. PubMed ID: 24670885
[TBL] [Abstract][Full Text] [Related]
34. Central hypothyroidism in infants who were born to mothers with thyrotoxicosis before 32 weeks' gestation: 3 cases.
Higuchi R; Miyawaki M; Kumagai T; Okutani T; Shima Y; Yoshiyama M; Ban H; Yoshikawa N
Pediatrics; 2005 May; 115(5):e623-5. PubMed ID: 15833889
[TBL] [Abstract][Full Text] [Related]
35. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy.
Momotani N; Hisaoka T; Noh J; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1992 Sep; 75(3):738-44. PubMed ID: 1517362
[TBL] [Abstract][Full Text] [Related]
36. [Clinical studeis on the regulatory system of thyroid hormone secretion and serum triiodothyronine. Part III. Studies on thyroid hormone change and its relationship when TSH in cases with subclinical hypothyroidism (Hashimoto's thyroiditis and 131I treated Graves' disease)].
Takeda Y
Nihon Naibunpi Gakkai Zasshi; 1975 Feb; 51(2):85-97. PubMed ID: 808432
[TBL] [Abstract][Full Text] [Related]
37. First trimester thyroid stimulating hormone as an independent risk factor for adverse pregnancy outcome.
Arbib N; Hadar E; Sneh-Arbib O; Chen R; Wiznitzer A; Gabbay-Benziv R
J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2174-2178. PubMed ID: 27677438
[TBL] [Abstract][Full Text] [Related]
38. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report.
Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC
Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424
[TBL] [Abstract][Full Text] [Related]
39. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.
Ueta Y; Fukui H; Murakami H; Yamanouchi Y; Yamamoto R; Murao A; Santou Y; Taniguchi S; Mitani Y; Shigemasa C
Thyroid; 1999 Feb; 9(2):179-82. PubMed ID: 10090319
[TBL] [Abstract][Full Text] [Related]
40. Serum thyrotropin in Graves' disease: a more reliable index of circulating thyroid-stimulating immunoglobulin level than thyroid function?
Kabadi UM; Premachandra BN
Endocr Pract; 2007 Oct; 13(6):615-9. PubMed ID: 17954417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
